This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Media Advisory: CIBC Employees Are Available To Share Stories About Why The Canadian Breast Cancer Foundation CIBC Run For The Cure Is Important To Them

TORONTO, Sept. 26, 2012 /CNW/ - CIBC's involvement in the Canadian Breast Cancer Foundation CIBC Run for the Cure started with a handful of dedicated and passionate employees, and over the last 20 years has grown into an important part of the fabric of our organization. Employees will be available in all 60 communities where the CIBC Run for the Cure takes place to tell their story about why they have become involved.

Below are stories from CIBC's eight Regional Run Champions. To speak to a Regional Run Champion or to a local Run Champion in your community please contact: Sean Hamilton, Director, External Communications and Media Relations, CIBC, Tel: 416-304-8456, Cell 416-886-2567 or email sean.hamilton@cibc.com

Karen Ringstead BC & Northern Territories  In Karen's 18 years of participation, her favourite Run moment was watching a recent survivor - a CIBC employee - with her whole family being cheered by Team CIBC upon crossing the finish line.

"I don't want to see cancer move into the fourth generation in our family," says Ringstead, whose Great Grandmother, Grandmother, Great Aunt and mother have all battled breast cancer. "I think it's so important to create awareness of early detection, minimizing risk and how we all can make a difference in fighting against breast cancer."

Sangeen Chahal Alberta  Sangeen has participated in the CIBC Run for the Cure for 11 years, the past five as a Run Champion, because she feels like she can make a difference and give back to her community.

"This cause does not just affect those with breast cancer, it affects everyone," says Chahal whose aunts, family, friends and a colleague have all battled the disease. "It makes me proud to work for an organization with such a strong community commitment. I still tear up today when I remember a client who asked to sit down with me to thank me for everything CIBC does for breast cancer research and awareness. She said that we are the reason she is here today." 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs